{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:25:22Z","timestamp":1793165122524,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jaad.2019.06.1288","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T12:42:48Z","timestamp":1562157768000},"page":"360-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial"],"prefix":"10.1016","volume":"82","author":[{"given":"Peter W.","family":"Hashim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Chima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Bares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinley","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Genece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace W.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Nia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gagliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2019.06.1288_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.06.1288_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/ced.12805","article-title":"Prevalence of psoriasis phenotypes among men and women in the USA","volume":"41","author":"Merola","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.06.1288_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2015.02.1127","article-title":"Genital psoriasis is associated with significant impairment in quality of life and sexual functioning","volume":"72","author":"Ryan","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.06.1288_bib4","first-page":"169","article-title":"Is facial involvement a sign of severe psoriasis?","volume":"18","author":"Canpolat","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.06.1288_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0190-9622(03)02793-2","article-title":"Facial psoriasis: comparison of patients with and without facial involvement","volume":"50","author":"Young Park","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.06.1288_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/reum.2018.80718","article-title":"Psoriasis in special localizations","volume":"56","author":"Dopytalska","year":"2018","journal-title":"Reumatologia"},{"issue":"2","key":"10.1016\/j.jaad.2019.06.1288_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","article-title":"Topical corticosteroids in psoriasis: strategies for improving safety","volume":"24","author":"Horn","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2019.06.1288_bib8","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archderm.141.9.1154","article-title":"Proven efficacy of tacrolimus for facial and intertriginous psoriasis","volume":"141","author":"Lebwohl","year":"2005","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.06.1288_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.06.1288_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.06.1288_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-\u03ba\u03b2 and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jaad.2019.06.1288_bib12","first-page":"390","article-title":"Crisaborole topical ointment, 2%: a nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","author":"Jarnagin","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.06.1288_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaad.2018.06.056","article-title":"Psoriasis: which therapy for which patient: focus on special populations and chronic infections","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.06.1288_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents","volume":"80","author":"Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.06.1288_bib15","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-4362.1993.tb02779.x","article-title":"Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy","volume":"32","author":"Lebwohl","year":"1993","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.06.1288_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mjd.2001.110046","article-title":"Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas","volume":"44","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.06.1288_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.06.1288_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaad.2008.06.041","article-title":"Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.06.1288_bib19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s11095-012-0946-7","article-title":"Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum","volume":"30","author":"Andrews","year":"2013","journal-title":"Pharm Res"},{"issue":"5","key":"10.1016\/j.jaad.2019.06.1288_bib20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40257-016-0204-6","article-title":"Tolerability of crisaborole ointment for application on sensitive skin areas: a randomized, double-blind, vehicle-controlled study in healthy volunteers","volume":"17","author":"Zane","year":"2016","journal-title":"Am J Clin Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221932287X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221932287X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:52:14Z","timestamp":1759272734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221932287X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S019096221932287X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1288","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}